Veterans Affairs awarded
Welireg (belzutifan) 40 mg
Starts May 21, 2026Ended May 22, 2026
The Department of Veterans Affairs has already agreed to pay Merck $23K. The job runs until May 22, 2026.
Traded May 2, 2026 · Filed May 5, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Welireg (belzutifan) 40 mg
Starts May 21, 2026Ended May 22, 2026
The Department of Veterans Affairs has already agreed to pay Merck $23K. The job runs until May 22, 2026.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.